Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Adc Therapeutics SA’s stock clocked out at $1.68, down -5.08% from its previous closing price of $1.77. In other words, the price has decreased by -$5.08 from its previous closing price. On the day, 0.6 million shares were traded. ADCT stock price reached its highest trading level at $1.81 during the session, while it also had its lowest trading level at $1.65.
Ratios:
To gain a deeper understanding of ADCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.68 and its Current Ratio is at 4.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $6.
On March 28, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.Guggenheim initiated its Buy rating on March 28, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 11 ’24 when Redmile Group, LLC bought 100,000 shares for $3.04 per share. The transaction valued at 304,500 led to the insider holds 15,666,731 shares of the business.
Redmile Group, LLC bought 100,000 shares of ADCT for $304,500 on Dec 11 ’24. The 10% Owner now owns 13,145,712 shares after completing the transaction at $3.04 per share. On Dec 04 ’24, another insider, Redmile Group, LLC, who serves as the 10% Owner of the company, sold 25,352 shares for $2.07 each. As a result, the insider received 52,479 and left with 15,566,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADCT now has a Market Capitalization of 162438528 and an Enterprise Value of 351264608. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.30. Its current Enterprise Value per Revenue stands at 4.967 whereas that against EBITDA is -2.566.
Stock Price History:
The Beta on a monthly basis for ADCT is 1.54, which has changed by -0.44859815 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, ADCT has reached a high of $6.04, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is -20.39%, while the 200-Day Moving Average is calculated to be -45.47%.
Shares Statistics:
It appears that ADCT traded 911.91K shares on average per day over the past three months and 499870 shares per day over the past ten days. A total of 96.69M shares are outstanding, with a floating share count of 77.58M. Insiders hold about 19.76% of the company’s shares, while institutions hold 69.03% stake in the company. Shares short for ADCT as of 1735603200 were 4859104 with a Short Ratio of 5.33, compared to 1732838400 on 3014605. Therefore, it implies a Short% of Shares Outstanding of 4859104 and a Short% of Float of 7.180000000000001.
